Letter by Chen et al Regarding Article, "Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial".
Letter by Chen et al Regarding Article, "Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial".
Circulation. 2020 Sep 08;142(10):e127-e128
Authors: Chen ZQ, Chen F, Li L
PMID: 32897750 [PubMed - as supplied by publisher]
Source: Circulation - Category: Cardiology Authors: Chen ZQ, Chen F, Li L Tags: Circulation Source Type: research
More News: Atrial Fibrillation | Cardiology | Dapagliflozin | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Forxiga